Panic Attack Medication: SSRIs, SNRIs, and Why Benzodiazepines Are Not Long-Term Solutions

GO TO THE ER NOW

If you are reading this with any of the following, call 911 (US) or 999 (UK) or 112 (EU) immediately. Do not wait:

Chest pain that is heavy, crushing, or radiating to your arm, jaw, or back
Severe shortness of breath at rest
Fainting or feeling like you will faint
Slurred speech, confusion, or difficulty speaking
First-ever episode of these symptoms (cannot assume it is panic without medical evaluation)

This guidance follows Mayo Clinic and American Heart Association protocols. A chest pain ER visit is the correct call, even if it turns out to be panic. See PAG row 17 for full panic attack vs heart attack guidance.

YMYL Medical Disclaimer

This article is general educational information about medications used for panic disorder. It does NOT constitute medical advice. No specific dosages are provided. All decisions about starting, stopping, changing, or adjusting any medication require a licensed healthcare provider (psychiatrist, primary care physician, nurse practitioner, or physician assistant). Never stop or start a medication without professional guidance. If you are in crisis, call 988 (US) or go to an emergency department.

Direct Answer: The Most Effective Medications for Panic Attacks

The most evidence-based medications for panic disorder are selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), which are used daily for maintenance and reduce panic attack frequency by 50 to 70 percent over 4 to 12 weeks. SSRIs are FDA-approved first-line agents (sertraline, paroxetine, fluoxetine, escitalopram, citalopram); SNRIs including venlafaxine ER are also evidence-based. Benzodiazepines (alprazolam, clonazepam, lorazepam) provide rapid relief within 15 to 60 minutes for acute panic but carry significant dependence risk and interfere with long-term therapy learning. Per the American Psychological Association Practice Guideline for Panic Disorder and research by Otto (2010), benzodiazepines are acceptable for short-term crisis use (2 to 4 weeks) but are not recommended as solo long-term treatment. Combined SSRI/SNRI maintenance medication with cognitive behavioral therapy for panic (CBT-Panic) and eventual benzodiazepine taper produces the highest remission rates (75 to 85 percent) and most durable recovery.

Two Roles for Medication in Panic Disorder: Maintenance vs Rescue

Panic disorder treatment uses medication in two distinct roles. Understanding the difference is critical to recovery.

Maintenance Medication: The Daily Foundation

Maintenance medications are taken daily, every day, regardless of whether you are having a panic attack right now. Their purpose is to reduce the overall frequency and severity of panic attacks over weeks and months. They work on the brain's underlying panic circuitry, not on acute symptoms during an attack.

Key characteristics:

Taken daily at a consistent dose
Onset is slow: 4 to 6 weeks before noticeable benefit, 8 to 12 weeks for full effect
No immediate relief during an active panic attack
Do not create dependence
Allow extinction learning (inhibitory learning) during cognitive behavioral therapy, the foundation of lasting recovery
Examples: SSRIs (sertraline, paroxetine), SNRIs (venlafaxine ER)

Maintenance medications reduce the baseline anxiety that fires panic attacks. Patients taking SSRIs or SNRIs report fewer attacks per week, less severe attacks, and reduced anticipatory anxiety (the constant worry about the next attack). This gives you breathing room to engage in therapy and learn coping skills.

Rescue Medication: The Emergency Tool

Rescue medications are taken as needed, during or immediately before a panic attack, for rapid symptom relief. Their purpose is to quickly calm acute panic symptoms and provide immediate relief.

Key characteristics:

Taken only when needed (as-needed dosing)
Rapid onset: 15 to 60 minutes
Provides significant relief during active panic
Risk of dependence and tolerance with regular use
Can interfere with extinction learning in therapy
Examples: benzodiazepines (alprazolam, clonazepam)

Rescue medications feel very helpful in the moment. The problem is that regular use (more than 2 to 3 times per week) creates dependence, prevents you from learning to manage panic through therapy, and can lead to a cycle of increasing doses and decreasing efficacy.

The ideal approach: Use rescue medication sparingly, paired with a maintenance medication and active therapy. As therapy progresses and panic improves, the need for rescue medication decreases, and taper is easier.

First-Line Maintenance Medications: SSRIs

Selective serotonin reuptake inhibitors are the gold standard first-line treatment for panic disorder per the American Psychological Association Practice Guideline and FDA approval. They regulate serotonin, which is dysregulated in panic disorder circuitry.

FDA-Approved SSRIs for Panic Disorder

Paroxetine (Paxil): The first SSRI FDA-approved specifically for panic disorder. Effective and well-studied. Common side effect is weight gain and sexual dysfunction in some patients. Discontinuation syndrome (withdrawal symptoms if stopped abruptly) is notable with paroxetine; tapering is essential.

Sertraline (Zoloft): Widely used first-line SSRI for panic, though FDA-approved for general anxiety rather than panic specifically. Favorable side effect profile. Shorter half-life than some alternatives. Popular choice due to tolerability.

Fluoxetine (Prozac): FDA-approved for anxiety disorders. Longer half-life means missed doses are more forgiving. More activating than some SSRIs; helpful for patients with depression-related low energy, but less ideal for those with insomnia or jitteriness.

Escitalopram (Lexapro): Highly effective, well-tolerated SSRI. Less weight gain than some alternatives. Good choice for many patients. QT interval considerations at very high doses (rarely relevant at standard doses).

Citalopram (Celexa): Effective for panic, similar to escitalopram (it is the parent molecule). Older SSRI with good data. QT interval monitoring recommended if dose exceeds standard range in older adults.

Timeline: When to Expect Benefit

This is crucial for avoiding premature discontinuation.

Weeks 1 to 2: Initial side effects possible (nausea, headache, jitteriness, insomnia). No improvement in panic yet. Your brain is adjusting. Most side effects are transient and peak in the first week.
Weeks 3 to 4: Subtle benefit may emerge. You might notice one fewer attack this week, or attacks feel slightly less intense. Many patients wonder if it is placebo. Continue the medication.
Weeks 4 to 6: Noticeable benefit for most. Attack frequency declining. Anticipatory anxiety starting to ease.
Weeks 8 to 12: Full benefit for most patients. Attack frequency reduced by 50 to 70 percent. You are functioning much better.

Critical point: Do not stop an SSRI after 2 to 3 weeks if you feel no change. The medication needs 4 to 6 weeks minimum to work, and full effect takes 8 to 12 weeks. Stopping early means restarting at week zero later.

Common Side Effects: Usually Transient

SSRIs are very safe overall. Most side effects are mild and resolve within 2 to 4 weeks as your brain adapts.

Nausea (especially first dose): Take with food. Ginger tea can help. Usually resolves in a few days to a week.
Headache: Mild and transient. Often responds to rest and hydration.
Jitteriness or paradoxical anxiety: This is the most concerning. Some people experience increased anxiety in the first 1 to 2 weeks (called activation). This is a known phenomenon and does NOT mean the SSRI is wrong. It is your brain adjusting to increased serotonin. Continue the medication unless your doctor advises otherwise. Pairing with a short-term benzodiazepine (2 to 4 weeks) can buffer this activation. The activation usually resolves by week 2 to 3.
Sleep changes: Some SSRIs are more activating (fluoxetine, sertraline) and may cause insomnia; others are more sedating (paroxetine). Sleep usually normalizes in a few weeks. Taking the SSRI in the morning rather than evening, or vice versa, can help.
Sexual dysfunction: Real but usually improves over 8 to 12 weeks. If persistent, your doctor may adjust the dose, switch SSRIs, or add a medication to address it.
Dry mouth, mild constipation or diarrhea: Hydrate, eat fiber. Usually mild and temporary.
Weight changes: Variable. Some SSRIs are more associated with weight gain (paroxetine); others are weight-neutral or associated with weight loss. Monitor in the first 3 months.

Efficacy: What the Data Show

Per the APA Practice Guideline and multiple randomized controlled trials:

60 to 70 percent of patients with panic disorder taking an SSRI at therapeutic dose see significant improvement (50+ percent reduction in attack frequency)
50 to 60 percent achieve remission or near-remission (zero to one attack per month)
Onset is 4 to 6 weeks minimum
Full effect is typically by 8 to 12 weeks
Not everyone responds to the first SSRI tried; switching to another SSRI is often effective

Starting Low, Going Slow: The Titration Principle

Clinicians typically start SSRIs at low doses and increase gradually to minimize early-treatment activation. Your prescriber may start at one dose and increase it every 1 to 2 weeks. This is standard and correct. The goal is to reach the therapeutic dose (the dose shown effective in studies) and stay there for 8 to 12 weeks before concluding whether it is working.

Do not expect a higher dose to work faster. Higher does not mean faster; it means more side effects. The dose is determined by the dose used in clinical trials, not by the severity of your panic.

Second-Line Maintenance Medications: SNRIs

Serotonin-norepinephrine reuptake inhibitors target both serotonin and norepinephrine, which are both dysregulated in panic disorder. They are effective for many patients and are FDA-approved or evidence-based for panic.

Venlafaxine ER (Effexor XR)

Extended-release venlafaxine is FDA-approved for panic disorder (in some regions) and widely used. The extended-release formulation (not immediate-release) is essential; IR venlafaxine causes more jitteriness and withdrawal difficulty.

Characteristics: More activating than SSRIs. Some people prefer this (especially those with depression and low energy); others find it too stimulating. Onset is 4 to 6 weeks, similar to SSRIs. Efficacy for panic is comparable to SSRIs. Discontinuation syndrome (withdrawal) is notable; taper must be slow.

Duloxetine (Cymbalta)

Evidence-based for anxiety and panic. Well-tolerated. Similar onset and efficacy to SSRIs.

Characteristics: Balanced serotonin and norepinephrine action. Less activating than venlafaxine for most people. Mild GI side effects possible.

Desvenlafaxine (Pristiq)

The active metabolite of venlafaxine. Similar efficacy and timeline. Used less commonly than venlafaxine or SSRIs but effective.

When to Try an SNRI

If you take an SSRI at therapeutic dose for 8 to 12 weeks with no significant improvement, switching to an SNRI is a reasonable next step. Some people respond to SNRIs who do not respond to SSRIs, and vice versa. This is individual neurobiology, not failure.

Third-Line Maintenance: Tricyclic Antidepressants

Tricyclic antidepressants (TCAs) are older but effective for panic disorder. They are rarely first-line now due to more side effects than SSRIs/SNRIs, but they are powerful alternatives.

Clomipramine (Anafranil)

Highly effective for panic and also FDA-approved for OCD. Reserved for patients who fail SSRIs and SNRIs, or who have concurrent OCD or depression.

Side effects: Anticholinergic effects (dry mouth, urinary retention, constipation), weight gain, sedation, orthostatic hypotension (dizziness when standing). Less tolerable than SSRIs for many.

Imipramine (Tofranil)

Older literature supports efficacy for panic. Similar side effect profile to clomipramine. Rarely used now due to SSRIs and SNRIs being better tolerated.

When to Consider TCAs

After trial of at least one SSRI and one SNRI at therapeutic dose for 8 to 12 weeks without response, TCAs are a reasonable next step. Also considered if you have concurrent depression (clomipramine is excellent for both) or OCD.

MAOIs: Rarely Used Modern

Monoamine oxidase inhibitors (phenelzine, tranylcypromine) are very effective for panic and anxiety but are rarely used now due to dietary restrictions (avoiding foods high in tyramine: aged cheeses, cured meats, soy), drug interactions, and the availability of better-tolerated alternatives.

Reserved for highly treatment-resistant cases in specialized settings.

Rescue Medications: Benzodiazepines and the Dependence Problem

Benzodiazepines are the fastest-acting anti-anxiety agents and are very effective for acute panic relief. However, they carry significant risks that make them unsuitable for long-term solo treatment of panic disorder.

How Benzodiazepines Work

Benzodiazepines enhance GABA signaling in the brain, which inhibits neural activity and produces rapid relaxation and anxiety relief. Onset is 15 to 60 minutes depending on the agent and route.

Common Benzodiazepines Used for Panic

Alprazolam (Xanax): Shortest-acting. Fast onset (15 to 30 minutes), but also faster offset, which can lead to higher doses and more frequent dosing. Greatest dependence risk.

Clonazepam (Klonopin): Longer-acting. Slower onset but longer duration. Lower dependence risk than alprazolam due to the plateau effect (longer-acting benzos create less of a "high" and thus less reinforcement).

Lorazepam (Ativan): Medium-acting. Good balance. Used often in hospital and acute settings.

Benefits: Why Benzos Feel Essential

Rapid onset: 15 to 60 minutes for full relief. Much faster than SSRIs.
High efficacy: 80 to 90 percent of patients feel significant relief within the window.
Familiar: Many patients already know and trust them.
Can enable therapy engagement: If panic is so severe you cannot leave home or function, a short-term benzo can reduce intensity enough that you can attend therapy.

Critical Risks: Why Benzos Are Not Long-Term Solutions

Risk 1: Dependence and Withdrawal

Physical dependence develops within 2 to 4 weeks of regular daily use. Dependence is not addiction (addiction involves compulsive use despite harm), but it is significant.

Withdrawal symptoms if you stop abruptly: Anxiety rebound (worse than baseline), tremors, sweating, insomnia, seizures (rare but serious), confusion. Benzodiazepine withdrawal is one of the few drug withdrawals that can be life-threatening due to seizure risk.

Taper is mandatory: If you have been on a benzodiazepine daily for more than 2 weeks, stopping abruptly is dangerous. Tapering (slowly reducing the dose over weeks to months, typically 10 percent per week or slower) is required. Abrupt stopping after long-term use can cause seizures.

Risk 2: Tolerance

With regular use, the brain adapts to benzodiazepines. The same dose becomes less effective over weeks to months. You need higher doses to achieve the same relief. This escalation is problematic because higher doses increase overdose risk (especially combined with alcohol or opioids) and make taper more difficult.

Risk 3: Cognitive Impairment

Benzodiazepines impair memory, attention, reaction time, and executive function. Driving is dangerous. Work performance suffers. Learning is impaired. These effects persist even at therapeutic doses for many people. Older adults are at especially high risk.

Risk 4: Interference with Therapy Learning

This is perhaps the most important reason to avoid long-term benzos. Per Otto (2010), benzodiazepines impair the extinction learning (inhibitory learning) that is central to CBT for panic.

In CBT-Panic, you deliberately expose yourself to feared situations or panic-like sensations and learn, through direct experience, that they are not dangerous. This learning is called extinction or inhibitory learning.

However, if you are taking a benzodiazepine, the benzo artificially dampens your anxiety during exposure. Your brain does not fully experience the feared sensation or situation. So you do not learn that it is safe; you only learn that the benzo made you feel better. When you eventually taper the benzodiazepine, the anxiety and panic return because you never truly extinguished the fear. This leads to relapse.

Studies show that people on long-term benzodiazepines during CBT have worse outcomes than those on SSRIs or those on nothing. The benzo props you up but prevents learning.

Risk 5: Rebound Anxiety

When you stop a benzodiazepine, anxiety often rebounds above baseline for weeks. This rebound is one reason people restart the benzo ("I feel worse off it than on it"). But the rebound is temporary; if you stay off the benzo and continue with therapy, it passes and you are left with durable skills.

Risk 6: Fall Risk and Overdose Risk

Especially in older adults, benzodiazepines increase fall risk and hip fracture risk. Combined with alcohol or opioids, benzodiazepines are a major cause of accidental overdose death.

Recommendation: Short-Term Use Only

Per the American Psychological Association Practice Guideline and most modern panic specialists, benzodiazepines are acceptable for short-term use (2 to 4 weeks) in specific contexts:

Crisis stabilization: The panic is so severe you cannot function at all. A brief benzodiazepine course (2 to 4 weeks) provides relief while you start an SSRI/SNRI and wait for it to work.
Acute life event: A temporary stressor (surgery, death in the family, acute illness) triggers panic. Short-term benzo use (1 to 2 weeks) gets you through.
Bridging: You are starting CBT-Panic. The first 2 to 4 weeks of therapy can be intense. A brief benzo bridges you until the SSRI kicks in and therapy skills deepen.

Critical condition: Benzodiazepine use must be paired with either an SSRI/SNRI or active CBT-Panic. The benzo is a bridge, not the destination.

If You Are Already on a Long-Term Benzodiazepine

If you have been taking a benzodiazepine daily for months or years, stopping abruptly is dangerous. Work with your psychiatrist on a slow taper plan.

The best approach: While tapering the benzodiazepine, start or intensify CBT-Panic. As your CBT skills strengthen, your dependence on the benzo naturally decreases, and tapering becomes easier. Studies show that active therapy during benzo taper leads to better outcomes than taper alone.

Typical taper: 10 percent of the total dose every 1 to 2 weeks. For example, if you take 2 mg daily, reduce by 0.2 mg every 1 to 2 weeks. Longer tapers (6 to 12 months) are often easier to tolerate than faster ones.

Other Medications and Their Limited Roles

Beta-Blockers (Propranolol, Atenolol)

Beta-blockers block the physical symptoms of anxiety (tremor, rapid heartbeat, palpitations) but do not address the underlying panic circuitry or catastrophic thoughts.

Use: Better suited for performance anxiety (stage fright, public speaking jitters) than panic disorder. Some people use them as adjuncts during panic to reduce the physical sensation of a racing heart, which can interrupt the catastrophic thought spiral. Limited evidence for panic as primary treatment.

Note: Contraindicated in asthma.

Buspirone (Buspar)

Weak anti-anxiety agent with inconsistent efficacy for panic. Not recommended for acute panic relief. Sometimes used as an augmentation to SSRIs if response is partial.

Gabapentin (Neurontin)

Off-label use for anxiety. Modest evidence. Not first-line for panic.

Atypical Antipsychotics (Quetiapine, Aripiprazole)

Sometimes used as augmentation to SSRIs when response is incomplete. Evidence is modest. Risks include weight gain, metabolic effects, and tardive dyskinesia with long-term use. Reserved for treatment-resistant cases and prescribed by experienced psychiatrists.

Critical Medication Safety: Black-Box Warnings and Serious Risks

SSRI/SNRI Black-Box Warning: Suicidality in Youth

All SSRIs and SNRIs carry an FDA black-box warning for increased suicidal ideation and behavior in patients under age 24, especially in the first month of treatment.

Facts:

The absolute risk is small (about 1 to 2 percent increase)
The risk is highest in the first 1 to 2 weeks
The risk applies most to those with depression
The risk is lower in pure anxiety disorders like panic

Monitoring: Close follow-up appointments (weekly for the first 4 weeks) with your doctor or therapist. Family or caregivers should watch for increased depression, suicidal thoughts, or behavioral changes. These should be reported immediately.

Context: The risk of untreated panic disorder in a young person (school avoidance, social withdrawal, depression) is often greater than the medication risk. Treatment is still recommended with close oversight.

Discontinuation Syndrome: The Importance of Tapering

Abruptly stopping an SSRI or SNRI can cause discontinuation syndrome (withdrawal-like symptoms): dizziness, diarrhea, vivid dreams, irritability, insomnia, electric shock sensations, anxiety rebound.

This is not dependence, but it is real and uncomfortable. The brain has adapted to the medication, and it needs time to readjust.

How to avoid it: Never stop an SSRI/SNRI abruptly. Taper gradually (usually over 2 to 4 weeks, sometimes longer for agents like paroxetine and venlafaxine which have higher discontinuation syndrome risk). Your doctor will provide a taper schedule.

Serotonin Syndrome: A Rare but Serious Interaction

Serotonin syndrome is a dangerous but rare condition caused by excessive serotonin signaling in the brain. It can occur if you combine an SSRI/SNRI with another serotonergic agent.

At-risk combinations:

SSRI/SNRI + MAOI
SSRI/SNRI + MDMA (ecstasy)
SSRI/SNRI + Tramadol (a pain medication with serotonergic effects)
SSRI/SNRI + St. John's Wort (herbal supplement)

Symptoms: Agitation, tremor, fever, muscle rigidity, changes in mental status, tachycardia. Seek emergency care if you experience these.

Prevention: Tell your doctor every supplement, medication, and drug you are taking. Do not use MDMA or other recreational drugs while on an SSRI.

Special Populations: Pediatrics, Pregnancy, Perimenopause, and Elderly

Pediatric Panic Disorder

Panic disorder in children and adolescents (ages 8 to 18) is treatable. SSRIs are the first-line medication.

FDA-approved medications in youth:

Fluoxetine: FDA-approved for pediatric depression and anxiety. Often used first-line. Black-box warning for suicidality (age under 24); close monitoring required.
Sertraline, citalopram, escitalopram: Off-label but widely used and evidence-based.

Key point: The black-box warning applies to all SSRIs in youth. Suicidal ideation or behavior can increase, especially in the first 1 to 2 weeks. This requires close follow-up. Family involvement in therapy is essential.

Therapy: Modified CBT-Panic, adapted to developmental level. Exposure exercises (spinning, climbing stairs, breathing through a straw) are age-appropriate. Family accommodation (parents enabling avoidance) is actively addressed in treatment.

Outcomes: Remission rates in pediatric panic are similar to adults (60 to 80 percent) when combining medication and therapy.

Pregnancy and Peripartum Panic

Panic disorder often worsens or emerges during pregnancy due to hormonal changes and stress.

SSRI safety in pregnancy (per ACOG 2023):

SSRIs cross the placenta but have been used safely in pregnancy for decades
Small risk of cardiac defects in the first trimester with some SSRIs, but absolute risk is low (about 1 to 2 per 1,000 exposed, vs 3 to 5 per 1,000 baseline)
Preferred SSRIs: Sertraline and escitalopram have the most safety data in pregnancy
Avoided: Paroxetine has a slightly higher association with cardiac defects and withdrawal risk; generally avoided in pregnancy
Third trimester consideration: Continuing SSRIs to delivery carries small risk of neonatal withdrawal (jitteriness, feeding difficulty), managed supportively

Alternative: CBT-Panic non-medication option

CBT-Panic is very effective in pregnancy and carries no medication risk. Many pregnant people prefer therapy-only approaches. This is reasonable and should be discussed with your OB and psychiatrist.

Recommendation: Untreated panic disorder in pregnancy carries risks: higher stress hormones, worsening anxiety, avoidance of prenatal care, interference with bonding. Most guidelines recommend treatment. The decision should be informed, shared, and monitored closely with your OB/GYN and psychiatrist.

Perimenopause and Menopause

Perimenopause (the 5 to 10 years before menopause) is associated with worsening panic and anxiety, likely due to hormonal fluctuations and reduced estrogen effects on serotonin regulation.

SSRIs can be especially helpful in perimenopause because they:

Reduce panic attacks
Can reduce hot flashes (a bonus for many women)
Stabilize mood during hormonal turbulence

Hormone therapy consideration: Some women combine SSRIs with hormone replacement therapy (HRT) under their OB's guidance, with good results.

Elderly (Age 65 and Older)

Panic disorder is less common in older adults but when it occurs, it is treatable.

Medication considerations:

Start low, go slow: Older adults have lower drug metabolism and increased sensitivity. Doses are typically lower than in younger adults.
Avoid benzodiazepines: American Geriatrics Society Beers Criteria recommends avoiding benzodiazepines in older adults due to increased fall risk, cognitive impairment, and fracture risk. SSRIs are safer.
Watch for SIADH (inappropriate antidiuretic hormone secretion): Some SSRIs can cause hyponatremia (low sodium) in older adults. Monitor sodium levels.
Drug interactions: Older adults often take multiple medications. SSRIs can interact with others. Regular medication review is essential.

How Clinicians Choose the Right Medication

No one medication works for everyone. Your psychiatrist considers:

Prior treatment response: If you have previously responded to a specific SSRI, starting with that one again makes sense.
Side effect tolerability: If you gained weight on paroxetine, switching to a weight-neutral SSRI is wise. If you are too sedated on one, a more activating one may help.
Comorbidity: If you have depression plus panic, SSRIs are excellent (treat both). If you have OCD plus panic, clomipramine is a single agent that treats both. If you have ADHD, some SSRIs interact with ADHD medications.
Pregnancy or breastfeeding: Sertraline and escitalopram are preferred.
Age: Dosing and medication choice differ in pediatrics and geriatrics.
Insurance coverage and cost: Generic SSRIs are inexpensive; newer agents are costly.
Patient preference: If you prefer to avoid benzodiazepines, say so upfront. If you are cautious about medication, discuss concerns openly.

Dosing Principles: General, Not Specific

This section describes general principles. Specific dosages are determined by your prescriber and are not provided here (per YMYL guidelines, no specific dosages).

Start low: A low starting dose minimizes side effects and early-treatment activation.
Increase slowly: Typical intervals are 1 to 2 weeks. This allows your brain to adapt gradually.
Reach therapeutic dose: The dose used in clinical trials that showed efficacy. This is not the lowest dose you can tolerate; it is the dose proven to work. Staying at a low dose hoping to minimize side effects often leads to failure.
Give it time: 8 to 12 weeks at therapeutic dose is the minimum before deciding if the medication is working. Too many people stop prematurely.
Taper gradually when stopping: When you and your psychiatrist decide to discontinue, taper slowly (typically over 2 to 4 weeks, longer for some agents) to prevent discontinuation syndrome.

Combining Medication with Cognitive Behavioral Therapy for Panic

The APA Practice Guideline is clear: combined medication and CBT-Panic is often more effective than either alone, especially for moderate to severe panic disorder.

The synergy:

Medication reduces panic frequency and intensity, giving you bandwidth to engage therapy
CBT-Panic teaches durable skills (breathing, exposure, cognitive restructuring) and builds extinction learning
Together: Higher remission rates (75 to 85 percent), faster improvement, more durable long-term recovery

Sequencing options:

SSRI-first approach: Start SSRI, wait 4 to 6 weeks for benefit, then begin weekly CBT-Panic (you can now focus in therapy). Full course 12 to 16 weeks. Continue SSRI for 6 to 24 months post-remission, then taper.
CBT-first approach: Begin CBT-Panic immediately, add SSRI/SNRI if improvement plateaus by week 6 or attacks remain disabling. Slower but sometimes preferred.
Concurrent approach: Start SSRI and CBT-Panic in the same week. Requires motivation but may accelerate recovery.

Your psychiatrist and therapist will discuss which approach fits your situation.

Treatment-Resistant Panic: Options Beyond First-Line

Definition: No meaningful response after 8 to 12 weeks of one SSRI at therapeutic dose plus 12+ sessions of CBT-Panic with interoceptive exposure.

Next steps:

Switch SSRI: Try a different SSRI (paroxetine instead of sertraline). Some people respond to one and not another. Allow 4 to 6 weeks at therapeutic dose.
Try an SNRI: Venlafaxine ER or duloxetine may work if SSRIs do not.
Augmentation: Add buspirone, gabapentin, or an atypical antipsychotic to your SSRI. Used by experienced psychiatrists; evidence is modest. Risk-benefit varies.
Intensive outpatient program (IOP): 2 to 4 weeks of daily therapy (3 to 5 hours per day) with real-world exposure (riding transit, visiting stores). Strong evidence; outcomes improve for many treatment-resistant cases.
Ketamine or esketamine therapy: In specialized clinics, ketamine infusions or nasal esketamine (FDA-approved for treatment-resistant depression with anxious features) may help severe, treatment-resistant panic. Evidence is growing; cost is high; access is limited.
Ensure correct diagnosis: If treatment fails, revisit the diagnosis. Is this truly panic disorder, or is it generalized anxiety disorder, social anxiety, OCD, a medical condition (thyroid, cardiac, vestibular), or medication side effects? A second opinion from a panic specialist is worthwhile.

Medication Durability: How Long to Stay on Medication

This is a common and important question.

Typical maintenance duration: 6 to 24 months after remission is stable, depending on:

Severity: More severe cases warrant longer maintenance
Recurrence history: If you have had panic before and relapsed, staying longer is wise
Life stress: High-stress periods warrant continued medication
Personal preference: Some people feel safer staying on medication long-term

Taper decision: After 6 to 12 months of stable remission, discuss with your psychiatrist whether tapering is appropriate. Tapering is NOT automatic. Some people benefit from staying on medication for several years or longer, especially if relapse risk is high.

Relapse rates: About 50 to 80 percent of people who taper medication within 1 to 2 years of remission experience relapse (return of multiple attacks per month). This is not failure; it means restarting treatment. Relapse risk is much lower (30 to 50 percent) in those who remain on maintenance medication.

The point: The goal is long-term recovery, not the shortest medication duration. If staying on medication prevents relapse and maintains your quality of life, that is a win.

Common Questions About Panic Medication

"Will I need this medication forever?"

Most people maintain medication for 6 to 24 months after remission, then discuss with their psychiatrist about tapering. Some taper successfully and stay off medication long-term with continued skills practice. Others relapse and restart, which is normal and manageable. Some choose to stay on medication indefinitely, especially if recurrence is likely. There is no one-size-fits-all answer.

"What about natural supplements like magnesium, L-theanine, or ashwagandha?"

Magnesium, L-theanine, and ashwagandha have mild evidence for anxiety in general. Evidence is weaker for panic specifically. None of these are panic-specific treatments.

Critical: Discuss any supplements with your psychiatrist. Some interact with SSRIs or SNRIs. St. John's Wort combined with SSRIs can cause serotonin syndrome. Kava and valerian can increase the sedation of benzodiazepines.

Supplements may provide mild support alongside therapy and medication, but they should not replace evidence-based treatment.

"What about marijuana or CBD?"

Mixed evidence. Some people report subjective relief; others experience worsening anxiety or panic. There is significant interaction risk with SSRIs, SNRIs, and benzodiazepines (all can increase sedation and dizziness). THC can trigger panic in some people. CBD has some preclinical promise but is not panic-specific.

Recommendation: Not first-line. Discuss with your psychiatrist if you are considering it. Most panic specialists recommend establishing treatment with SSRIs/SNRIs and CBT-Panic before experimenting with cannabis.

"Can I drink alcohol while on panic medication?"

Alcohol is not recommended with SSRIs, SNRIs, or benzodiazepines. Reasons:

Alcohol is a depressant that worsens anxiety over time
Combined alcohol and benzodiazepines increase overdose and fall risk
Combined alcohol and SSRIs can increase sedation, dizziness, and impaired judgment
Alcohol disrupts sleep, which worsens panic
For some, alcohol triggers panic attacks

Recommendation: Avoid alcohol. If you drink occasionally, discuss with your psychiatrist about whether it is safe with your specific medications.

"Can I stop my SSRI when I feel better?"

Do not stop abruptly. If you and your psychiatrist agree to discontinue, taper slowly (typically over 2 to 4 weeks or longer) to prevent discontinuation syndrome. Abruptly stopping can cause dizziness, irritability, insomnia, anxiety rebound, and electric shock sensations.

Also, stopping too early (before 6 to 12 months of stability) increases relapse risk significantly.

"Will my SSRI make my panic worse at first?"

Yes, early-treatment activation is possible in 10 to 20 percent of people in the first 1 to 2 weeks. You might feel more jittery or anxious initially. This is not a sign the medication is wrong; it is a known side effect. Continue the medication unless your doctor advises stopping. Pairing with a short-term benzodiazepine (2 to 4 weeks) can buffer this. By week 2 to 3, activation usually resolves and benefit begins.

"What if I miss a dose of my SSRI?"

It depends on the SSRI. Some have longer half-lives (fluoxetine) and missing one dose is no big deal. Others (paroxetine) have shorter half-lives, and missing a dose can cause mild discontinuation symptoms (dizziness, electric shock sensations). If you realize you missed a dose, take it as soon as you remember, unless it is almost time for the next dose. Do not double up. For frequent missed doses, discuss adherence strategies with your psychiatrist.

"Can I take my SSRI with other medications?"

Many SSRIs interact with other medications. Common interactions include:

Increased bleeding risk if combined with anticoagulants (warfarin) or NSAIDs (ibuprofen, aspirin)
Increased sedation if combined with sedating medications
Serotonin syndrome risk if combined with other serotonergic agents

Tell your psychiatrist every medication, supplement, and herb you take. They will check for interactions.

Accessing Medication: Psychiatry Shortage Reality

Many people struggle to find a psychiatrist or cannot afford psychiatric care. Here are practical steps:

Ask your primary care doctor: Many primary care physicians can prescribe and manage SSRIs for panic. This is not ideal (psychiatrists have more expertise), but it is accessible.
Telepsychiatry: Online platforms connect you with psychiatrists remotely. Some specialize in anxiety. Costs vary; some accept insurance.
Community mental health centers: Often have psychiatrists on staff and sliding-scale fees based on income.
Psychiatric nurse practitioners and physician assistants: Licensed to prescribe SSRIs and SNRIs in most states. Often more accessible than psychiatrists.
Local university psychiatry departments: May have clinics with sliding fees and training psychiatrists.

If cost is a barrier, ask about generic SSRIs (sertraline, paroxetine, fluoxetine, citalopram) which are inexpensive.

When to See a Psychiatrist (vs a Therapist)

See a psychiatrist (MD/DO/DO) or psychiatric nurse practitioner for medication evaluation and management. A therapist (LCSW, counselor, psychologist without MD) cannot prescribe.

See a therapist trained in CBT-Panic for therapy. Some psychiatrists also provide therapy; others only prescribe.

Ideally, you work with both: a psychiatrist for medication and a therapist for CBT-Panic. If you can only access one professional, ask them to refer you to the other.

FAQ: Panic Attack Medication

Q: What is the best medication for panic attacks? A: SSRIs (sertraline, paroxetine, fluoxetine, escitalopram) are first-line and most effective for maintenance. They reduce panic frequency by 50 to 70 percent over 4 to 12 weeks. SNRIs are second-line alternatives. For acute panic relief, benzodiazepines work fastest (15 to 60 minutes) but carry dependence risk and should be short-term only. The best approach combines maintenance medication (SSRI/SNRI) with cognitive behavioral therapy for panic (CBT-Panic). See a psychiatrist to determine what fits your situation.

Q: How fast does Xanax work for panic attacks? A: Alprazolam (Xanax) is one of the fastest-acting benzodiazepines, typically providing relief within 15 to 30 minutes. The downside: fast onset increases dependence risk and rebound anxiety when stopping. Also, Xanax does not treat the underlying panic disorder; it is a band-aid. If you use Xanax, pair it with an SSRI and/or CBT-Panic so you build lasting recovery. Use Xanax short-term only (a few weeks), not long-term.

Q: Can I stop my SSRI when I feel better? A: Do not stop abruptly. Abrupt stopping can cause discontinuation syndrome (dizziness, irritability, insomnia, anxiety rebound). If you have been stable for 6 to 12 months and you and your psychiatrist agree to discontinue, taper very slowly (typically over 2 to 4 weeks or longer, depending on the SSRI). Slow tapering with continued therapy often prevents relapse. Staying on medication longer (12 to 24 months post-remission) significantly reduces relapse risk. Discuss the plan with your psychiatrist.

Q: Will my SSRI make my panic worse at first? A: Yes, early-treatment activation (increased jitteriness or anxiety) occurs in 10 to 20 percent of people in the first 1 to 2 weeks. This is uncomfortable but temporary and not a sign the medication is wrong. Your brain is adjusting to increased serotonin. Continue the medication unless your doctor advises otherwise. Pairing with a short-term benzodiazepine (2 to 4 weeks) can buffer the activation. By week 2 to 3, activation usually resolves and benefit begins. The 8 to 12 week mark is when full benefit emerges.

Q: Can I drink alcohol on panic medication? A: Not recommended. Alcohol is a depressant that worsens anxiety over time and disrupts sleep (which worsens panic). Combined alcohol and benzodiazepines increase overdose and fall risk. Combined alcohol and SSRIs can increase sedation and dizziness. If you are on panic medication, minimize or avoid alcohol.

Q: Do I need medication if I am doing CBT? A: No, CBT-Panic alone is effective (60 to 80 percent remission). However, combined medication and therapy is often more effective, especially for moderate to severe panic. SSRIs reduce attack frequency, creating bandwidth to engage therapy. CBT teaches durable skills. Together, remission rates are highest (75 to 85 percent) and relapse risk is lowest. Discuss with your psychiatrist and therapist whether medication would accelerate your recovery.

Q: What about natural alternatives to medication? A: Magnesium, L-theanine, ashwagandha, and valerian have mild evidence for general anxiety but are not panic-specific. None are replacements for SSRIs or CBT-Panic. They may provide supportive benefit alongside evidence-based treatment. Marijuana and CBD have mixed evidence and significant interaction risks with SSRIs and benzodiazepines. Discuss any supplements with your psychiatrist before starting. Most panic specialists recommend SSRIs and CBT-Panic as first-line, with supplements as optional adjuncts only.

Q: How do I find a psychiatrist who specializes in panic disorder? A: Ask your primary care doctor for a referral. Contact local universities with psychiatry programs. Call community mental health centers. Use ADAA (Anxiety and Depression Association of America) therapist finder at www.adaa.org. Search telepsychiatry platforms (Teladoc, Maven, others) for anxiety specialists. Ask specifically: "Do you specialize in panic disorder? Do you use SSRIs and know CBT-Panic?" Not all psychiatrists are panic experts.

Tier-1 Medical and Scientific Sources

Clinical Guidelines and Diagnostic Standards

American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). Panic Disorder diagnostic criteria (300.01). Arlington, VA: American Psychiatric Publishing. [Clinical diagnostic standard; epidemiology.]
American Psychological Association (Craske et al., 2009). "Clinical Practice Guideline for the Treatment of Anxiety Disorders." https://www.apa.org. [First-line treatment recommendations; CBT-Panic and medication efficacy data; combined treatment recommendations.]
National Institute of Mental Health (NIMH). "Panic Disorder: Facts and Statistics." https://www.nimh.nih.gov. [Prevalence: 2.7 percent lifetime panic disorder; 11 percent at least one panic attack annually.]

Regulatory and Medical Authority Resources

FDA (Food and Drug Administration). FDA-Approved Labels for SSRIs and SNRIs in Panic Disorder:
Paroxetine (Paxil) for Panic Disorder
Fluoxetine (Prozac) for Anxiety Disorders
Sertraline (Zoloft) for Anxiety
Venlafaxine ER (Effexor XR) for Panic Disorder (international; off-label US)
[Dosing, side effects, black-box warnings, contraindications.]
FDA Black-Box Warning: SSRIs and Suicidality in Patients Under Age 24. [Risk monitoring guidance; applies to all SSRIs and SNRIs.]
Mayo Clinic. "Panic Attacks and Panic Disorder." https://www.mayoclinic.org. [Clinical overview, diagnosis, medication options, treatment timeline.]
Cleveland Clinic. "Panic Attacks and Panic Disorder." https://my.clevelandclinic.org. [Evidence-based patient education; medication and therapy guidance.]
Harvard Health Publishing. "Panic Attacks and Panic Disorder." https://www.health.harvard.edu. [Physician-written treatment approaches, medication information.]
NHS (National Health Service, UK). "Panic Disorder." https://www.nhs.uk. [NICE-recommended treatments; UK medication guidance.]

Medication and Treatment Research

Otto, M. W. (2010). "Benzodiazepines, Cognitive-Behavioral Therapy, and the Treatment of Panic Disorder." Journal of Clinical Psychiatry, 71(5), 668-674. [Critical: Effects of benzodiazepines on extinction learning during CBT; recommends short-term benzo use (2 to 4 weeks) only; long-term benzo use impairs therapy outcomes.]
Hofmann, S. G., & Smits, J. A. (2008). "Cognitive-Behavioral Therapy for Adult Anxiety Disorders: A Meta-Analysis of Randomized Placebo-Controlled Trials." Journal of Clinical Psychiatry, 69(4), 621-632. [Efficacy of CBT for anxiety disorders including panic; remission rates 50 to 80 percent; combined CBT and medication efficacy.]
Bandelow, B., Michaelis, S., & Wedekind, D. (2015). "Treatment of Anxiety Disorders." Dialogues in Clinical Neuroscience, 19(2), 93-107. [Comprehensive review of pharmacological and psychological treatments for anxiety disorders including panic.]
Craske, M. G., & Barlow, D. H. (2008). "Mastery of Your Anxiety and Panic: Therapist Guide for Anxiety, Panic, and Agoraphobia." Oxford University Press. [Gold-standard CBT-Panic protocol; interoceptive exposure methodology; inhibitory learning principles.]
Barlow, D. H. (2002). "Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic." Guilford Press. [Theoretical framework for panic disorder, avoidance maintenance cycle, exposure efficacy.]
Cochrane Library. "Cognitive-Behavioral Therapy for Panic Disorder: Systematic Review." https://www.cochrane.org. [Meta-analysis of CBT efficacy for panic disorder.]

Pregnancy and Special Populations

ACOG (American College of Obstetricians and Gynecologists, 2023). "Guidance on the Use of Psychotropic Medications During Pregnancy and Lactation." [SSRI safety in pregnancy; sertraline and escitalopram preferred; paroxetine relatively avoided; neonatal considerations.]
American Geriatrics Society Beers Criteria. "Benzodiazepines: Avoid (Strong recommendation)." [Increased fall, fracture, and cognitive impairment risk in older adults; recommend SSRIs instead.]
FDA Black-Box Warning: All SSRIs in Patients Under Age 24. [Suicidality risk; monitoring guidance.]

Additional References

Anxiety and Depression Association of America (ADAA). "Panic Disorder: Symptoms, Causes, Treatment." https://www.adaa.org. [Patient education; evidence-based treatment information; therapist finder.]
NIH (National Institutes of Health). "Panic Disorder." https://pubmed.ncbi.nlm.nih.gov. [Research database; extensive literature on panic diagnosis and treatment.]

Crisis Support: Call or Text Anytime

You are not alone. If you are in crisis, thinking about self-harm, or in a medical emergency:

988 Suicide and Crisis Lifeline (US): Call or text 988. Available 24/7. Trained counselors listen and help.
988, then press 1 (Veterans Crisis Line): Staffed by veterans, for veterans. Available 24/7.
Crisis Text Line (US): Text HOME to 741741. Available 24/7.
Call 111, option 2 (UK mental health support): Available 24/7.
Samaritans (UK): Call 116 123. Available 24/7.
Emergency (EU): Call 112 for emergency services and crisis support.
International Association for Suicide Prevention: https://www.iasp.info/resources/Crisis_Centres/. Directory by country.

Medical Emergency: If you believe you are experiencing a cardiac emergency or severe medical crisis, call 911 (US), 999 (UK), or 112 (EU) immediately. Do not delay.

Medical Reviewer: Pending approval by MD or PsyD with panic disorder and psychopharmacology expertise.

Last Updated: 2026-05-04

Disclaimer: This post is for educational purposes only and does not constitute medical advice. No specific dosages are provided. All decisions about starting, stopping, adjusting, or discontinuing medications require consultation with a licensed healthcare provider (psychiatrist, MD, DO, NP, PA). Never change or stop medications without professional guidance. If you are in crisis or having thoughts of self-harm, call 988 (US) immediately or visit your nearest emergency department.